Amylyx Pharmaceuticals Inc (AMLX)
5.715
+0.08
(+1.33%)
USD |
NASDAQ |
Nov 04, 16:00
5.70
-0.02
(-0.26%)
After-Hours: 04:17
Amylyx Pharmaceuticals Total Assets (Quarterly): 332.16M for June 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | 332.16M |
| March 31, 2024 | 417.46M |
| December 31, 2023 | 517.45M |
| September 30, 2023 | 466.58M |
| June 30, 2023 | 453.59M |
| March 31, 2023 | 407.96M |
| December 31, 2022 | 391.45M |
| Date | Value |
|---|---|
| September 30, 2022 | 181.44M |
| June 30, 2022 | 225.24M |
| March 31, 2022 | 274.44M |
| December 31, 2021 | 105.61M |
| September 30, 2021 | 130.46M |
| December 31, 2020 | 14.10M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
14.10M
Minimum
Dec 2020
517.45M
Maximum
Dec 2023
301.38M
Average
332.16M
Median
Jun 2024
Total Assets (Quarterly) Benchmarks
| PTC Therapeutics Inc | 1.916B |
| NovaBay Pharmaceuticals Inc | 3.925M |
| Palatin Technologies Inc | 10.74M |
| iBio Inc | 28.73M |
| Theriva Biologics Inc | 42.39M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 70.85M |
| Shareholders Equity (Quarterly) | 261.31M |
| Current Ratio | 4.662 |